Egito ES - Search Results

1

Amphotericin B microemulsion reduces toxicity and maintains the efficacy as an antifungal product.

Damasceno BP, Dominici VA, Urbano IA, Silva JA, Araújo IB, Santos-Magalhães NS, Silva AK, Medeiros AC, Oliveira AG, Egito ES. Damasceno BP, et al. Among authors: egito es. J Biomed Nanotechnol. 2012 Apr;8(2):290-300. doi: 10.1166/jbn.2012.1374. J Biomed Nanotechnol. 2012. PMID: 22515080

2

Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity.

Egito ES, Araújo IB, Damasceno BP, Price JC. Egito ES, et al. J Pharm Sci. 2002 Nov;91(11):2354-66. doi: 10.1002/jps.10223. J Pharm Sci. 2002. PMID: 12379920

3

Influence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systems.

Siqueira SD, Silva-Filho MA, Silva CA, Araújo IB, Silva AE, Fernandes-Pedrosa MF, Oliveira AG, Egito ES. Siqueira SD, et al. Among authors: egito es. AAPS PharmSciTech. 2014 Jun;15(3):612-9. doi: 10.1208/s12249-014-0085-z. Epub 2014 Feb 8. AAPS PharmSciTech. 2014. PMID: 24510525 Free PMC article.

4

Similarity between the in vitro activity and toxicity of two different Fungizone/Lipofundin admixtures.

Araújo IB, Brito CR, Urbano IA, Dominici VA, Silva Filho MA, Silveira WL, Damasceno BP, Medeiros AC, Egito ES. Araújo IB, et al. Among authors: egito es. Acta Cir Bras. 2005;20 Suppl 1:257-61. Acta Cir Bras. 2005. PMID: 16186987 Free article.

5

Influence of a lipophilic drug on the stability of emulsions: an important approach on the development of lipidic carriers.

Formiga FR, Fonseca IA, Souza KB, Silva AK, Macedo JP, Araújo IB, Soares LA, Egito ES. Formiga FR, et al. Among authors: egito es. Int J Pharm. 2007 Nov 1;344(1-2):158-60. doi: 10.1016/j.ijpharm.2007.05.052. Epub 2007 May 29. Int J Pharm. 2007. PMID: 17614224

6

Development of superparamagnetic microparticles for biotechnological purposes.

Silva AK, Egito ES, Nagashima-Junior T, Araujo IB, Silva EL, Soares LA, Carrico AS. Silva AK, et al. Among authors: egito es. Drug Dev Ind Pharm. 2008 Oct;34(10):1111-6. doi: 10.1080/03639040801973669. Drug Dev Ind Pharm. 2008. PMID: 18777238

7

Synthesis and characterization of xylan-coated magnetite microparticles.

Silva AK, da Silva EL, Oliveira EE, Nagashima T Jr, Soares LA, Medeiros AC, Araújo JH, Araújo IB, Carriço AS, Egito ES. Silva AK, et al. Among authors: egito es. Int J Pharm. 2007 Apr 4;334(1-2):42-7. doi: 10.1016/j.ijpharm.2006.10.019. Epub 2006 Oct 13. Int J Pharm. 2007. PMID: 17113734

8

Getting the Jump on the Development of Bullfrog Oil Microemulsions: a Nanocarrier for Amphotericin B Intended for Antifungal Treatment.

Oliveira WN, Amaral-Machado L, Alencar EN, Marcelino HR, Genre J, Silva-Rocha WP, Gondim AD, Chaves GM, Fernandes-Pedrosa MF, Egito EST. Oliveira WN, et al. AAPS PharmSciTech. 2018 Aug;19(6):2585-2597. doi: 10.1208/s12249-018-1093-1. Epub 2018 Jun 18. AAPS PharmSciTech. 2018. PMID: 29916194

9

Development of oil-in-water microemulsions for the oral delivery of amphotericin B.

Silva AE, Barratt G, Chéron M, Egito ES. Silva AE, et al. Among authors: egito es. Int J Pharm. 2013 Oct 1;454(2):641-8. doi: 10.1016/j.ijpharm.2013.05.044. Epub 2013 May 31. Int J Pharm. 2013. PMID: 23726904 Free article.

10

Evaluation of the relationship of the molecular aggregation state of amphotericin B in medium to its genotoxic potential.

Egito LC, de Medeiros SR, Medeiros MG, Price JC, Egito ES. Egito LC, et al. Among authors: egito es. J Pharm Sci. 2004 Jun;93(6):1557-65. doi: 10.1002/jps.20038. J Pharm Sci. 2004. PMID: 15124213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters